Effects of terlipressin on pulmonary artery pressure in a septic cooled infant: An echocardiographic assessment

Journal of Perinatology

Volumn 32, Issue 11, 2012, Pages 893-895

  Radicioni, M ^a   Troiani, S ^a   Camerini, P G ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Hypertension pulmonary; hypothermia induced; infant newborn; shock septic; terlipressin

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; FUROSEMIDE; NITRIC OXIDE; NORADRENALIN; TERLIPRESSIN; TROPONIN;

ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CESAREAN SECTION; DISEASE EXACERBATION; DIURESIS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; HEART VENTRICLE FUNCTION; HUMAN; HYPOTENSION; INDUCED HYPOTHERMIA; INFANT; LUNG ARTERY PRESSURE; LUNG CIRCULATION; MALE; OLIGURIA; OXYGEN CONSUMPTION; PARENTAL CONSENT; PERINATAL ASPHYXIA; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RESUSCITATION; TACHYCARDIA; TREATMENT RESPONSE; TRICUSPID VALVE REGURGITATION; URINE VOLUME; VASCULAR RESISTANCE; WARMING;

ANTIHYPERTENSIVE AGENTS; ASPHYXIA NEONATORUM; DISEASE PROGRESSION; EPINEPHRINE; HUMANS; HYPERTENSION, PULMONARY; HYPOTHERMIA, INDUCED; INFANT, NEWBORN; LYPRESSIN; MALE; NOREPINEPHRINE; PULMONARY CIRCULATION; SHOCK; TRICUSPID VALVE INSUFFICIENCY; TROPONIN; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 84868583198     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.181     Document Type: Article

References (20)

1. Morelli A, Ertmer C, Pietropaoli P, Westphal M. Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. Expert Opin Pharmacother 2009; 10 2569-2575.
2. Gluud LL, Christensen K, Christensen E, Krag A. Systematic review of randomized trial on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 2010; 51:576-584
3. Filippi L, Gozzini E, Daniotti M, Pagliai F, Catarzi S, Fiorini P. Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr Crit Care Med 2011; 12:1-5.
4. Filippi L, Poggi C, Serafini L, Fiorini P. Terlipressin as rescue treatment of refractory shock in a neonate. Acta Paediatr 2008; 97:500-502.
5. Leone M, Martin C. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock. Best Pract Res Clin Anaesthesiol 2008; 22:323-333.
6. Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004; 5:116-118.
7. Papoff P, Caresta E, Versacci P, Grossi R, Midulla F, Moretti C. The role of terlipressin in the management of severe pulmonary hypertension in congenital diaphragmatic hernia. Pediatr Anesth 2009; 19:805-806.
8. Stathopoulos L, Nicaise C, Michel F, Thomachot L, Merrot T, Lagier P et al. Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic hernia. J Pediatr Surg 2011; 46: E19-E21.
9. Pesaturo AB, Jennings HR, Voils SA. Terlipressin: vasopressin analog and novel drug for septic shock. Ann Pharmacother 2006; 40:2170-2177.
10. Westphal M, Stubbe H, Sielenkämper AW, Borgulya R, Van Aken H, Ball C et al. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003; 29:301-308.
11. Westphal M, Stubbe H, Sielenkämper AW, Ball C, Van Aken H, Borgulya R et al. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 2003; 31:1502-1508.
12. Albanèse J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 2005; 33:1897-1902.
13. Torgersen C, Dünser MW, Wenzel V, Jochberger S, Mayr V, Schmittinger CA et al. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med 2010; 36:57-65.
14. Lange M, Ertmer C, Westphal M. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 2008; 34:821-832.
15. Scheurer MA, Scott MB, Atz AM. Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return. J Thorac Cardiovasc Surg 2005; 129:464-466.
16. Price LC, Forrest P, Sodhi V, Adamson DL, Nelson-Piercy C, Lucey M et al. Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 2007; 99:552-555.
17. Kalambokis GN, Pappas K, Tsianos EV. Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study. Angiology; e-pub ahead of print 6 July 2011.
18. Skinner JR, Boys RJ, Heads A, Hey EN, Hunter S. Estimation of pulmonary arterial pressure in the newborn: study of the repeatability of four Doppler echocardiographic techniques. Pediatr Cardiol 1996; 17:360-369.
19. Chemla D, Lambert V, Losay J. Mean pulmonary artery pressure estimated from systolic and diastolic pulmonary artery pressure in children with congenital heart disease: an invasive study. Pediatr Cardiol 2009; 30:1137-1142.
20. Kluckow M. Functional echocardiography in assessment of the cardiovascular system in asphyxiated neonates. J Pediatr 2011; 158: e13-e18.